CPH 0.00% 0.9¢ creso pharma limited

Ann: Creso Reports Strong Financial Performance in FY22, page-5

  1. 1,923 Posts.
    lightbulb Created with Sketch. 581
    https://hotcopper.com.au/data/attachments/5090/5090769-166bc9aec5392726f84096f14cdd5c06.jpg


    I just made it really easy for you to understand...most of these options(green) have an exercise price way out of the money and unless the share price goes to 20c to 80c+, most will be expired/cancelled worthless in 2023 or 2024. So, in other words, it's good news. Either the share price does go that high or the options get cancelled. Does that help...
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.